Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
MACC1 is a prognostic and predictive metastasis biomarker for more than 20 solid cancer entities. However, its role in cancer metabolism is not sufficiently explored. Here, we report on how MACC1 impacts the use of glucose, glutamine, lactate, pyruvate and fatty acids and show the comprehensive analysis of MACC1-driven metabolic networks. We analyzed concentration-dependent changes in nutrient use, nutrient depletion, metabolic tracing employing C-labeled substrates, and in vivo studies. We found that MACC1 permits numerous effects on cancer metabolism. Most of those effects increased nutrient uptake. Furthermore, MACC1 alters metabolic pathways by affecting metabolite production or turnover from metabolic substrates. MACC1 supports use of glucose, glutamine and pyruvate via their increased depletion or altered distribution within metabolic pathways. In summary, we demonstrate that MACC1 is an important regulator of metabolism in cancer cells.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956336 | PMC |
| http://dx.doi.org/10.3390/cancers13050978 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Discovery of tetrazolo-pyridazine-based small molecules as inhibitors of MACC1-driven cancer metastasis.
Biomed Pharmacother
December 2023
Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin, and Max-Delbrück-Center for Molecular Medicine, Robert-Rössle-Str. 10, 13125 Berlin, Germany; German Cancer Consortium (DKTK Partnersite Berlin), Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld 280, 691
Metastasis is directly linked to poor prognosis of cancer patients and warrants search for effective anti-metastatic drugs. MACC1 is a causal key molecule for metastasis. High MACC1 expression is prognostic for metastasis and poor survival.
View Article and Find Full Text PDFInsulin-like Growth Factor Binding Protein-2 (IGFBP2) Is a Key Molecule in the MACC1-Mediated Platelet Communication and Metastasis of Colorectal Cancer Cells.
Int J Mol Sci
November 2021
Pharmaceutical Department, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany.
Article Synopsis
- Tumor cell interactions with platelets play a crucial role in the spread of cancer, particularly in colorectal cancer (CRC), where the oncogene MACC1 is a key player in promoting metastasis and serves as a prognostic biomarker.
- The study investigated how MACC1 affects platelet activation through its impact on a molecule called IGFBP2, which was found to influence platelet communication and activation by scavenging signals that typically promote such processes.
- Findings suggest that IGFBP2 functions as an important link in the MACC1-driven metastasis mechanism, enhancing cancer cell migration and invasiveness, and its role was further validated in an in vivo mouse model.
Systematic Identification of MACC1-Driven Metabolic Networks in Colorectal Cancer.
Cancers (Basel)
February 2021
German Cancer Consortium, Deutsches Krebsforschungzentrum (DKFZ), 69120 Heidelberg, Germany.
Article Synopsis
- MACC1 is identified as a significant biomarker for predicting metastasis in over 20 types of solid cancers, but its influence on cancer metabolism had not been thoroughly studied.
- The research highlights how MACC1 affects the metabolism of key nutrients like glucose, glutamine, lactate, pyruvate, and fatty acids, showcasing its role in enhancing nutrient uptake and modifying metabolic pathways.
- The findings suggest that MACC1 is a crucial player in regulating cancer cell metabolism, enabling changes in nutrient utilization and the turnover of metabolic products.
MACC1 regulates clathrin-mediated endocytosis and receptor recycling of transferrin receptor and EGFR in colorectal cancer.
Cell Mol Life Sci
April 2021
Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine Berlin in the Helmholtz-Association, Robert-Rössle-Straße 10, 13125, Berlin, Germany.
Metastasis Associated in Colon Cancer 1 (MACC1) is a novel prognostic, predictive and causal biomarker for tumor progression and metastasis in many cancer types, including colorectal cancer. Besides its clinical value, little is known about its molecular function. Its similarity to SH3BP4, involved in regulating uptake and recycling of transmembrane receptors, suggests a role of MACC1 in endocytosis.
View Article and Find Full Text PDFPro-inflammatory TNF-α and IFN-γ Promote Tumor Growth and Metastasis via Induction of MACC1.
Front Immunol
April 2021
Experimental and Clinical Research Center, Charité Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Colorectal cancer (CRC) is one of the most common malignancies worldwide. Early stage CRC patients have a good prognosis. If distant metastasis occurs, the 5-year survival drops below 10%.
View Article and Find Full Text PDF